Arrowhead Pharmaceuticals, Inc.

VOYA INVESTMENT MANAGEMENT LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

422,731

Value ($000)

28,065

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	28,065	0.0%	422,731	12/31/2025
2025 Q3	10/9/2025	4,743	0.0%	137,516	9/30/2025
2025 Q2	8/14/2025	842	0.0%	53,264	6/30/2025
2025 Q1	5/15/2025	410	0.0%	32,184	3/31/2025
2024 Q4	5/2/2025	1,011	0.0%	53,793	12/31/2024
2024 Q3	2/7/2025	5,818	0.0%	300,366	9/30/2024
2024 Q2	2/7/2025	7,157	0.0%	275,393	6/30/2024
2024 Q1	2/7/2025	5,421	0.0%	189,540	3/31/2024
2023 Q4	2/7/2025	5,983	0.0%	195,526	12/31/2023
2023 Q3	2/7/2025	5,052	0.0%	188,023	9/30/2023
2023 Q2	2/7/2025	8,203	0.0%	230,045	6/30/2023
2023 Q1	2/7/2025	6,070	0.0%	238,957	3/31/2023
2022 Q4	2/7/2025	10,763	0.0%	265,362	12/31/2022
2022 Q3	2/7/2025	8,621	0.0%	260,849	9/30/2022
2022 Q2	8/15/2022	8,032	0.0%	228,111	6/30/2022
2022 Q1	5/16/2022	6,905	0.0%	150,132	3/31/2022
2021 Q4	2/14/2022	7,051	0.0%	106,349	12/31/2021
2021 Q3	11/15/2021	16,750	0.0%	268,313	9/30/2021
2021 Q2	8/16/2021	22,213	0.0%	268,215	6/30/2021
2021 Q1	5/17/2021	18,604	0.0%	280,580	3/31/2021
2020 Q4	2/16/2021	22,693	0.0%	295,747	12/31/2020
2020 Q3	11/16/2020	15,522	0.0%	360,459	9/30/2020
2020 Q2	8/14/2020	16,049	0.0%	371,611	6/30/2020
2020 Q1	5/15/2020	13,606	0.0%	472,933	3/31/2020
2019 Q4	2/14/2020	27,504	0.1%	433,617	12/31/2019